CD40 and dermatomyositis: It inhibited the expression of surface markers CD40, CD80, and MHC-II in patients with DM DCs (Figure 3A) and BMDCs (Figure 4A) but only suppressed the presence of surface marker CD80 in patients with DR DCs (Figure 5A).